HAE vs UFPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HAE Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Haemonetics Corporation (HAE) driven by superior Valuation, Momentum & Technical, Options & Structure while UFPT counters with relative strength in Growth & Margin. Fundamentally, HAE trades at 22.9x Forward P/E with 18.8% operating margin (+9.3% YoY revenue) versus UFPT at 24.7x Forward P/E and 15.4% operating margin (+11.6% YoY). In options structure, HAE sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HAE | UFPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.6B | $2.4B | Larger Scale | HAE |
| Trailing P/E Ratio Valuation | 54.4x | 31.2x | Lower Multiple | UFPT |
| Forward P/E Ratio Valuation | 22.9x | 24.7x | Lower Multiple | HAE |
| Revenue Growth (YoY) Growth | +9.3% | +11.6% | Higher Growth | UFPT |
| Operating Margin (TTM) Profitability | 18.8% | 15.4% | Higher Margin | HAE |
| Net Profit Margin Profitability | 7.5% | 11.8% | Higher Margin | UFPT |
| Return on Equity (ROE) Capital Efficiency | 11.9% | 17.2% | Higher ROE | UFPT |
| 52-Week Range Position Momentum | 87% ($51โ$132) | 74% ($174โ$342) | Stronger Trend | HAE |
| Beta / 30D Volatility Risk Regime | 0.27ฮฒ ยท 32% Vol | 1.64ฮฒ ยท 77% Vol | Lower Realized Risk | HAE |
| Unified Institutional Score Composite Signal | 51.4 / 100 (HOLD) | 42.6 / 100 (HOLD) | Higher Composite | HAE |